Trial country
AustraliaAustriaBelgiumCanadaChinaCzech RepublicDenmarkEgyptFinlandFranceGermanyIsraelItalyJapanMexicoNetherlandsNew ZealandNorwayPolandRussiaSingaporeSouth KoreaSpainSwedenSwitzerlandTaiwanUKUSA Multi-country
Principal investigator
Disease category
Cancer diseasesCardiovascular diseasesGene markingHealthy volunteersInfectious diseasesMonogenic diseasesNeurological diseasesOcular diseases Others
Indication
Clinical phase
II/IIIIII/IIIIII
Trial status
OpenClosedWithdrawnOn clinical holdConditional approvalNever initiatedCanceledUnder reviewSubmission not completeDuplicate Submission of US-697
Year approved/initiated
1989199019911992199319941995199619971998199920002001200220032004200520062007